BiotechTube
Home/RevolKa/Norio Hamamatsu, Ph.D.
NH

Norio Hamamatsu, Ph.D.

President and CEO

RevolKa

Therapeutic Areas

Rare Diseases

RevolKa Pipeline

DrugIndicationPhase
Rare Disease Drug Discovery ProgramUndisclosed Rare DiseasesPreclinical

Leadership Team at RevolKa

MU
Mitsuo Umetsu, Ph.D.
Chief Scientific Officer
View full RevolKa profile